CD20 count analysis is a laboratory test used to measure the levels of CD20-positive cells, which are a type of white blood cell that play an important role in the immune response. CD20 cells are targeted in certain therapies, particularly for the treatment of specific cancers such as lymphoma. This test is usually performed as part of a comprehensive patient evaluation, as it can provide vital information about the presence or absence of immune or malignant disorders. The CD20 count helps guide treatment plans and allows physicians to monitor the patient’s response to therapy. Although results may vary depending on overall health status and other factors, CD20 analysis is a valuable tool in the diagnosis and follow-up of many diseases.